GEHCNASDAQ— GE HealthCare Technologies Inc. Price & Analysis

GE HealthCare Technologies Inc.

HEALTHCARE — MEDICAL DEVICES

$68.86

-$0.86-1.23%

Market Cap: $31.49B; Large Cap
P/E Ratio: 16.06; Fwd: 12.9
EPS (TTM): $4.34
Div. Yield: 0.20%

Technical Summary

RSI (14)41.60Neutral

SMA (50)$68.28Bullish

SMA (200)$72.68Bearish

MACD0.3983Bearish

Bollinger$69.28 – $75.76Lower

Stochastic9.55Oversold

Theo Outlook

GE HealthCare Technologies (GEHC) presents a bullish thesis with a trailing P/E of 15.87, market capitalization of $31.32 billion, TTM revenue of $21.27 billion, and EPS of $4.34. Quarterly revenue growth of 5.8% and EPS growth of 16.8% year-over-year support a constructive view, as the stock trades at a forward P/E of 12.79 with an analyst target price of $82.50. Key catalysts include strong earnings momentum from the medical devices and pharmaceutical diagnostics segments, ongoing digital solutions expansion, and recent product launches in imaging and ultrasound. Market expansion in emerging regions and a 19.4% return on equity further bolster growth prospects amid healthcare technology demand. Risks encompass regulatory hurdles in FDA approvals, intense competition from Siemens Healthineers and Philips, and macro headwinds from healthcare spending cuts. Mitigations include diversified revenue streams, 94% institutional ownership providing stability, and a conservative balance sheet with low dividend payout. Analysis generated by HeyTheo AI based on SEC filings, earnings transcripts, and market data.

Analysis generated by HeyTheo AI on Sep 7, 2026.

Company Overview

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Fundamental Snapshot

Revenue: $21.27B
EBITDA: $3.59B
Gross Profit: $8.41B
Operating Margin: 15.0%
Profit Margin: 9.3%
ROE: 19.4%
Book Value: $24.30
Beta: 0.82
52-Wk High: $89.64
52-Wk Low: $58.72
Avg Volume: 2.76M
PEG Ratio: 1.76

Frequently Asked Questions

What is GE HealthCare's business model?

GEHC operates as a medical technology company providing imaging, ultrasound, patient monitoring, and pharmaceutical diagnostics. It generates revenue primarily through equipment sales, service contracts, and recurring consumables, with TTM revenue of $21.27 billion.

What are GEHC's main revenue sources?

Revenue comes from medical imaging systems, ultrasound, life care solutions, and pharmaceutical diagnostics. TTM revenue reached $21.27 billion with 5.8% quarterly growth, supported by high-margin service and digital offerings.

What competitive advantages does GEHC hold?

GEHC benefits from strong brand recognition, a broad installed base driving recurring revenue, and leadership in AI-enhanced imaging. Its 19.4% ROE and 15.87 trailing P/E reflect efficient operations versus peers.

What are the key risks for GEHC investors?

Primary risks include regulatory delays, competition from larger medtech firms, and potential healthcare budget pressures. The stock's 0.2% dividend yield and $31.32B market cap provide some downside cushion amid macro uncertainty.

What is the growth outlook for GEHC?

Analysts target $82.50 with a forward P/E of 12.79, driven by digital health expansion and 16.8% EPS growth. Next earnings momentum and 50-day moving average of $68.29 suggest continued upside potential.